1-5 of 5
Michael Kundi, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intensive Post-Remission Consolidation with G-CSF-Support: Tolerability, Safety, Reduced Hospitalization, and Efficacy of a New Treatment Protocol for AML Patients ≥60 Years

Wolfgang R. Sperr, MD, Susanne Herndlhofer, Karoline V Gleixner, MD, Michael Girschikofsky, MD, Ansgar Weltermann, MD, Sigrid Machherndl-Spandl, MD, Thamer Sliwa, MD, Rainer Poehnl, MD, Buxhofer-Ausch Veronika, MD, Karin Strecker, MD, Paul Knoebl, MD, Ulrich Jaeger, Klaus Geissler, MD, Michael Kundi, MD, Peter Valent, MD
Journal: Blood
Blood (2016) 128 (22): 2797.
https://doi.org/10.1182/blood.V128.22.2797.2797
Published: 2016
Journal Articles

Prognostic Factors and Survival Prediction in 1,088 Patients with Mastocytosis Collected in the Registry of the European Competence Network on Mastocytosis (ECNM Registry)

Wolfgang R. Sperr, MD, Michael Kundi, MD, Hanneke Oude Elberink, MD, Björn van Anrooij, MD, Karoline V Gleixner, MD, Emir Hadzijusufovic, DVM, Aleksandra Górska, MD, Magdalena Lange, MD, Anja Rabenhorst, PhD, Serena Merante, MD, Chiara Elena, MD, Anna Belloni Fortina, MD, Elena Fontana, MD, Juliana Schwaab, MD, Mohamad Jawhar, MD, Roberta Zanotti, MD, Patrizia Bonadonna, MD, Massimo Triggiani, MD, Cecelia Perkins, MPH, Jason R. Gotlib, MD, Michael Doubek, Khalid Shoumaryeh, MD, David Fuchs, MD, Vito Sabato, MD, Knut Brockow, MD, Agnes Bretterklieber, MD, Nadja Jaekel, MD, Andreas Reiter, MD, Karin Hartmann, MD, Marek Niedoszytko, MD, Hanneke C. Kluin-Nelemans, MD PhD, Peter Valent, MD
Journal: Blood
Blood (2016) 128 (22): 396.
https://doi.org/10.1182/blood.V128.22.396.396
Published: 2016
Journal Articles

Serum Tryptase Is a Strong Predictive Biomarker That Improves Prognostication in Ph+ Chronic Myeloid Leukemia.

Wolfgang R. Sperr, M.D., Thomas Pfeiffer, Michael Kundi, MD, Christian Sillaber, MD, Susanne Herndlhofer, Peter Valent, MD
Journal: Blood
Blood (2012) 120 (21): 2783.
https://doi.org/10.1182/blood.V120.21.2783.2783
Published: 2012
Journal Articles

Karyotype Plus NPM1 Mutation Status Defines a Group of Elderly Patients with AML (≥60 Years) Who Benefit From Intensive Post-Induction Consolidation Therapy

Wolfgang R. Sperr, MD, Otto Zach, PhD, Iris Poell, Michael Kundi, MD, Susanne Herndlhofer, Ulrich Jaeger, MD, Paul Knoebl, MD, Ansgar Weltermann, MD, Peter Valent, M.D.
Journal: Blood
Blood (2011) 118 (21): 2504.
https://doi.org/10.1182/blood.V118.21.2504.2504
Published: 2011
Journal Articles

Prognostic Significance of Serial Determinations of LDH Levels in Primary ( De Novo ) Myelodysplastic Syndromes.

Friedrich Wimazal, MD, Wolfgang R. Sperr, MD, Anja Vales, MD, Michael Kundi, MD, Alexandra Boehm, MD, Renate Thalhammer, MD, Ilse Schwarzinger, MD, Peter Valent, MD
Journal: Blood
Blood (2006) 108 (11): 4828.
https://doi.org/10.1182/blood.V108.11.4828.4828
Published: 2006